International Patent: USE OF A CYP11A1 INHIBITOR FOR THE TREATMENT OF BREAST, OVARIAN, OR ENDOMETRIAL CANCERS

GENEVA, Oct. 30 -- MERCK SHARP & DOHME LLC filed a patent application (IB2026/053989) for “USE OF A CYP11A1 INHIBITOR FOR THE TREATMENT OF BREAST, OVARIAN, OR ENDOMETRIAL CANCERS”. With publication no. WO/2026/224643, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/404

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....